PUBLISHED DATE : Jul 2022 | Pages : 151
Fill out your details & get your free sample
The U.S. Fertility Test Market Research Report Includes Size by
Product-
Gender
Distribution Channel
End-users
Trends, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022-2027
151 Pages
47 Tables
73 Charts
1 Regions
1 Countries
26 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE(2027) | USD 201.4 MILLION |
| MARKET SIZE(2021) | USD 133.5 MILLION |
| CAGR(2022-2027) | 7.09% |
| BASE YEAR | 2021 |
| FORECAST YEAR | 2022-2027 |
| MARKET SEGMENTS | Product (Ovulation Test Kits, Fertility Monitors, and Sperm Test Kits), Gender (Male and Female), Distribution Channel (Online Sales Channel, Retail Pharmacies, and Hospital Pharmacies), End-user (Homecare, Fertility & Specialty Clinics, and Hospitals) |
| LARGEST MARKET BY PRODUCT | Ovulation Test kits |
| LARGEST SALES CHANNELS | Online Sales |
| COUNTRY COVERED | U.S. |
U.S. fertility test market is projected to reach USD 201.4 million in 2027 from USD 133.5 million in 2021, growing at a CAGR of 7.09 %. A fertility test is a procedure by which the fertility of males or females can assess and search the fertile window during a month. Fertility tests are assessed by ovulation test kits, fertility monitors, and sperm testing. The increasing infertility prevalence and rising maternal age directly impact male and female fertility, driving the demand for fertility tests. The U.S. fertility test market is likely to develop due to favorable demographic and social/cultural shifts due to attractive long-term growth.
With the help of testing, gynecologists/doctors quickly analyze the barrier factors that restrict the pregnancy. Moreover, the increasing awareness in teenagers and maternal age groups, both men and women, is driving the demand for home care kits. The rapidly advancing medical device industry has made a significant impact on the growth of the global fertility test market. The industry is highly competitive, and the vendors are increasingly focused on making partnerships and broadening the product portfolio to maintain a competitive edge over other players.
Increasing Adoption of At-Home Fertility Testing Kits.
As per the National Centre for Biotechnology Information study report, home-based fertility testing devices are easy to use and provide accurate results that are easy to understand. The introduction of digital display with test kits also made it easier to interpret the results, which propelled the higher adoption of the kits leading to the growth of the market. The availability of fertility tests such as ovulation test kits. Fertility monitors and sperm test kits by e-commerce channels, hospitals pharmacies, and retail pharmacies give tremendous opportunity for market growth.
Due to the rising concern and increasing awareness, the male fertility sperm test is also made widely available. Most of the time, men hesitate to visit clinics or fertility centers for testing. They can do the same at the convenience of their home using home test kits. As fertility services are costly in the U.S., patients opt for at-home fertility testing kits to test, monitor and conceive.
Rising Concern About Infertility And Increasing Hospital Visits.
The government support for family planning and reproductive health has helped raise fertility-related awareness in the U.S. The U.S. government has supported people for reproductive health (R.H.) and family planning (F.P.) for the last 50 years. It has now shifted the focus on the concern about fertility problems. The U.S. is a large market for fertility tests and services.
The ovulation test kit market accounted for more than 56% of the U.S. fertility test market share due to the increasing population of first-time pregnancies in maternal age groups and the increasing prevalence of infertility cases across the U.S. Some women experience irregular ovulation in the U.S., which triggers the market growth to determine the fertility window and the menstrual cycle. Around 10% of males in the United States suffer from infertility problems. The growing prevalence of infertility cases in males due to external factors such as consumption of alcohol, tobacco, and marijuana and environmental pollution are escalating the demand for sperm test kits.
In the United States, the female segment accounted for more than 70% of the share in 2021 due to the change in women's lifestyles and rising awareness about personal health. Due to the high acceptance of fertility testing kits as compared to males. Reproduction-related issues and the high prevalence of hormonal disorders such as PCOS drive market growth.
The rising adoption of E-commerce channels for consumable healthcare products has fuelled the sales of fertility testing kits online. The availability of a wide range of products on online sales channels concerning the price competitiveness; buyers can easily compare products before buying. Increasing internet penetration and the rising smartphone population will give a new opportunity for market growth. The availability of digital fertility testing kits created a unique opportunity in the U.S. market. The online sales channel is projected to sell more fertility test kits than retail pharmacies and hospital pharmacies. The online market is expected to grow at a CAGR of more than 7% from 2022 to 2027.
By Product
By Gender
By Distribution Channel
By End-users
Frequently Asked Questions
What is the total value of the U.S. fertility test market by 2027?
The U.S. fertility test market is projected to reach USD 201.37 million by 2027.
By 2027 which sales channel will sell more fertility test kits?
Online sales channel is projected to sell more fertility test kits than retail pharmacies and hospital pharmacies. The online market is expected to grow at a CAGR of more than 7% from 2022-2027.
What are the key trends in the U.S. fertility testing industry?
The key trends in the industry are the rising prevalence of sperm kits amongst men, more preference for online buying channels and, increasing hormonal disorders amongst women.
Ovulation test kits are expected to garner the highest traction.
The U.S. fertility test market size was valued at USD 133.49 million in 2020 and is expected to reach USD 201.37 million by 2026, growing at a CAGR of 7.09 % during the forecast period
The following factors are likely to contribute to the growth of the U.S. fertility test market-
Base Year: 2021
Forecast Year: 2022-2027
The study considers a detailed scenario of the present U.S. fertility test market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Key Vendors
Segmentation by Product-
Segmentation by Gender
Segmentation by Distribution Channel
Segmentation by End-users
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY GENDER
4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
4.3.4 MARKET SEGMENTATION BY END USER
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 INCREASING ADOPTION OF AT-HOME FERTILITY TESTING KITS
8.2 LATE MARRIAGES AND PREGNANCY TRENDS IN THE US
8.3 RISING ACCEPTANCE OF SPERM TEST KITS BY MEN
9 MARKET GROWTH ENABLERS
9.1 RISING CONCERN OVER INFERTILITY AND INCREASING HOSPITAL VISITS
9.2 INCREASING MATERNAL AGE & LATE MARRIAGES
9.3 PREVALENCE OF INFERTILITY-CAUSING DISEASES
9.4 INCREASING AWARENESS OF FERTILITY PROBLEMS
10 MARKET RESTRAINTS
10.1 ALTERNATIVE TEST OPTIONS FOR FERTILITY TEST KITS
10.2 ACCURACY & KNOWLEDGE OF FERTILITY CARE
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.1.1 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: PRODUCT SEGMENTATION INSIGHTS
11.1.2 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: GENDER SEGMENTATION INSIGHTS
11.1.3 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: DISTRIBUTION CHANNEL SEGMENTATION INSIGHTS
11.1.4 US FERTILITY TEST MARKET SHARE ANALYSIS 2021 & 2027: END-USER SEGMENTATION INSIGHTS
11.2 MARKET SIZE & FORECAST
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRODUCT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.2.1 INCREMENTAL & ABSOLUTE GROWTH BY PRODUCT
12.3 PRODUCT
12.4 OVULATION TEST KIT
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.5 FERTILITY MONITORS
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.6 SPERM TEST KITS
12.6.1 MARKET OVERVIEW
12.6.2 MARKET SIZE & FORECAST
13 GENDER
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.2.1 INCREMENTAL GROWTH & ABSOLUTE GROWTH BY GENDER SEGMENT
13.3 GENDER
13.4 FEMALE
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.5 MALE
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
14 DISTRIBUTION CHANNEL
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.2.1 INCREMENTAL GROWTH & ABSOLUTE GROWTH BY GENDER SEGMENT
14.3 DISTRIBUTION CHANNEL
14.4 ONLINE SALES CHANNEL
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 RETAIL PHARMACIES
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.6 HOSPITAL PHARMACIES
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.2.1 INCREMENTAL GROWTH & ABSOLUTE GROWTH BY END-USER
15.3 END-USER
15.4 HOMECARE
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.5 FERTILITY & SPECIALTY HOSPITALS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 HOSPITALS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
16 COMPETITIVE LANDSCAPE
16.1 COMPETITION OVERVIEW
16.2 MARKET SHARE ANALYSIS
16.2.1 AB ANALITICA
16.2.2 ADVACARE PHARMA
16.2.3 BIOZHENA
16.2.4 DNA DIAGNOSTICS CENTER
16.2.5 FAIRHAVEN HEALTH
16.2.6 HILIN LIFE
17 KEY COMPANY PROFILES
17.1 AB ANALITICA
17.1.1 BUSINESS OVERVIEW
17.1.2 PRODUCT OFFERINGS
17.2 ADVACARE PHARMA
17.2.1 BUSINESS OVERVIEW
17.2.2 PRODUCT OFFERINGS
17.3 BIOZHENA
17.3.1 BUSINESS OVERVIEW
17.3.2 PRODUCT OFFERINGS
17.4 DNA DIAGNOSTICS CENTER
17.4.1 BUSINESS OVERVIEW
17.4.2 PRODUCT OFFERINGS
17.5 VIO HEALTH TECH
17.5.1 BUSINESS OVERVIEW
17.5.2 PRODUCT OFFERINGS
17.6 FAIRHAVEN HEALTH
17.6.1 BUSINESS OVERVIEW
17.6.2 PRODUCT OFFERINGS
17.7 HAMILTON THORNE
17.7.1 BUSINESS OVERVIEW
17.7.2 PRODUCT OFFERINGS
17.8 HILIN LIFE PRODUCTS
17.8.1 BUSINESS OVERVIEW
17.8.2 PRODUCT OFFERINGS
17.9 GIVE LEGACY
17.9.1 BUSINESS OVERVIEW
17.9.2 PRODUCT OFFERINGS
17.10 IXENSOR
17.10.1 BUSINESS OVERVIEW
17.10.2 PRODUCT OFFERINGS
17.11 LADY TECHNOLOGIES
17.11.1 BUSINESS OVERVIEW
17.11.2 PRODUCT OFFERINGS
17.12 LETSGETCHECKED
17.12.1 BUSINESS OVERVIEW
17.12.2 PRODUCT OFFERINGS
17.13 MEDICAL ELECTRONIC SYSTEMS
17.13.1 BUSINESS OVERVIEW
17.13.2 PRODUCT OFFERINGS
17.14 MODERN FERTILITY
17.14.1 BUSINESS OVERVIEW
17.14.2 PRODUCT OFFERINGS
17.15 NATALIST
17.15.1 BUSINESS OVERVIEW
17.15.2 PRODUCT OFFERINGS
17.16 OOVA
17.16.1 BUSINESS OVERVIEW
17.16.2 PRODUCT OFFERINGS
17.17 PREMOM
17.17.1 BUSINESS OVERVIEW
17.17.2 PRODUCT OFFERINGS
17.18 QUANOVATE
17.18.1 BUSINESS OVERVIEW
17.18.2 PRODUCT OFFERINGS
17.19 RAIING MEDICAL
17.19.1 BUSINESS OVERVIEW
17.19.2 PRODUCT OFFERINGS
17.20 SUGENTECH
17.20.1 BUSINESS OVERVIEW
17.20.2 PRODUCT OFFERINGS
17.21 SAMPLYTICS TECHNOLOGIES PRIVATE LIMITED
17.21.1 BUSINESS OVERVIEW
17.21.2 PRODUCT OFFERINGS
17.22 SWIMCOUNT
17.22.1 BUSINESS OVERVIEW
17.22.2 PRODUCT OFFERINGS
17.23 SWISS PRECISION DIAGNOSTICS
17.23.1 BUSINESS OVERVIEW
17.23.2 PRODUCT OFFERINGS
17.24 TECO DIAGNOSTICS
17.24.1 BUSINESS OVERVIEW
17.24.2 PRODUCT OFFERINGS
17.25 UEBE MEDICAL
17.25.1 BUSINESS OVERVIEW
17.25.2 PRODUCT OFFERINGS
17.26 VALLEY ELECTRONICS
17.26.1 BUSINESS OVERVIEW
17.26.2 PRODUCT OFFERINGS
18 REPORT SUMMARY
18.1 KEY TAKEAWAYS
18.2 STRATEGIC RECOMMENDATIONS
19 QUANTITATIVE SUMMARY
19.1 PRODUCT
19.2 GENDER
19.3 DISTRIBUTION CHANNEL
19.4 END-USER
20 APPENDIX
20.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF US FERTILITY TESTS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 COMMON CAUSES OF INFERTILITY (% SHARE)
EXHIBIT 4 SYMPTOMS OF INFERTILITY AMONG MEN AND WOMEN
EXHIBIT 5 BIRTH RATE BY MATERNAL AGE PER 1,000 WOMEN IN US 2017-2019
EXHIBIT 6 IMPACT OF INCREASING ADOPTION OF AT-HOME FERTILITY TESTING KITS
EXHIBIT 7 US: BIRTH RATE BY MATERNAL AGE PER 1,000 WOMEN 2017-2019
EXHIBIT 8 IMPACT OF LATE MARRIAGES & PREGNANCY TRENDS IN THE US
EXHIBIT 9 US: DELAY IN MARRIAGE PER 1,000 POPULATION (%)
EXHIBIT 10 US: MEDIAN AGE AT FIRST MARRIAGE (1980-2021)
EXHIBIT 11 IMPACT OF RISING ACCEPTANCE OF SPERM TEST KITS BY MEN
EXHIBIT 12 IMPACT OF RISING CONCERN OVER INFERTILITY & INCREASING HOSPITAL VISITS
EXHIBIT 13 US WOMEN & THEIR PARTNERS SEEKING FERTILITY SERVICES TO BECOME PREGNANT (2015-2017)
EXHIBIT 14 IMPACT OF INCREASING MATERNAL AGE & LATE MARRIAGES
EXHIBIT 15 US BIRTH RATE BY MATERNAL AGE 2017-2019
EXHIBIT 16 IMPACT OF PREVALENCE OF INFERTILITY-CAUSING DISEASES
EXHIBIT 17 INFERTILITY CAUSING DISEASES AMONG MEN & WOMEN
EXHIBIT 18 IMPACT OF INCREASING AWARENESS OF FERTILITY PROBLEMS
EXHIBIT 19 IMPACT OF ALTERNATIVE TEST OPTIONS FOR FERTILITY TEST KITS
EXHIBIT 20 IMPACT OF ACCURACY & KNOWLEDGE OF FERTILITY CARE
EXHIBIT 21 US FERTILITY TEST MARKET BY PRODUCT
EXHIBIT 22 US FERTILITY TEST MARKET BY GENDER
EXHIBIT 23 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS
EXHIBIT 24 US FERTILITY TEST MARKET BY END-USER
EXHIBIT 25 US FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 26 FIVE FORCES ANALYSIS 2021
EXHIBIT 27 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 28 US FERTILITY TEST MARKET BY PRODUCTS 2021-2027
EXHIBIT 29 US FERTILITY TEST MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 30 US FERTILITY TEST MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 31 ADVANTAGES OF OVULATION TEST
EXHIBIT 32 US FERTILITY TEST MARKET BY OVULATION TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 33 US FERTILITY TEST MARKET BY OVULATION TEST KIT 2021–2027 ($ MILLION)
EXHIBIT 34 US: PERCENTAGE OF BIRTH BY MATERNAL AGE
EXHIBIT 35 US FERTILITY TEST MARKET BY FERTILITY MONITORS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 36 US FERTILITY TEST MARKET BY FERTILITY MONITORS 2021–2027 ($ MILLION)
EXHIBIT 37 CAUSES OF MALE INFERTILITY
EXHIBIT 38 US: FACTORS CAUSING MALE INFERTILITY
EXHIBIT 39 US FERTILITY TEST MARKET BY SPERM TEST KITS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 40 US FERTILITY TEST MARKET BY SPERM TEST KITS 2021–2027 ($ MILLION)
EXHIBIT 41 INCREMENTAL GROWTH BY GENDER 2021 & 2027
EXHIBIT 42 US FERTILITY TEST MARKET BY GENDER 2021-2027
EXHIBIT 43 US FERTILITY TEST MARKET BY GENDER: INCREMENTAL GROWTH
EXHIBIT 44 US FERTILITY TEST MARKET BY GENDER: ABSOLUTE GROWTH
EXHIBIT 45 US: AVERAGE NUMBER OF BIRTH PER WOMEN
EXHIBIT 46 US BIRTH RATE BY RACIAL & ETHNIC GROUPS 2020 (%)
EXHIBIT 47 US: TEEN BIRTH RATE PER 1,000 FEMALE AMONG 15 TO 19-YEAR-OLDS
EXHIBIT 48 US: WOMEN AGED 35 TO 44 YEARS REPORTING FERTILITY TREATMENTS 2019 (%)
EXHIBIT 49 US FERTILITY TEST MARKET BY FEMALE: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 50 US FERTILITY TEST MARKET BY FEMALE 2021–2027 ($ MILLION)
EXHIBIT 51 US FERTILITY TEST MARKET BY MALE: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 52 MALE FERTILITY TEST MARKET IN US 2021–2027 ($ MILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 54 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021-2027
EXHIBIT 55 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS: INCREMENTAL GROWTH
EXHIBIT 56 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS: ABSOLUTE GROWTH
EXHIBIT 57 US FERTILITY TEST MARKET BY ONLINE SALES CHANNELS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 58 US FERTILITY TEST MARKET BY ONLINE SALES CHANNEL 2021–2027 ($ MILLION)
EXHIBIT 59 GLOBAL FERTILITY TEST MARKET BY RETAIL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 60 US FERTILITY TEST MARKET BY RETAIL PHARMACIES 2021–2027 ($ MILLION)
EXHIBIT 61 US FERTILITY TEST MARKET BY HOSPITAL PHARMACIES: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 62 US FERTILITY TEST MARKET BY HOSPITAL PHARMACIES 2021–2027 ($ MILLION)
EXHIBIT 63 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 64 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021-2027
EXHIBIT 65 US FERTILITY TEST MARKET BY END USER: INCREMENTAL GROWTH
EXHIBIT 66 US FERTILITY TEST MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 67 FERTILITY TEST PRODUCTS IN HOMECARE
EXHIBIT 68 US FERTILITY TEST MARKET BY HOMECARE: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 69 US HOMECARE FERTILITY TEST MARKET 2021–2027 ($ MILLION)
EXHIBIT 70 US FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 71 US FERTILITY TEST MARKET BY SPECIALTY & FERTILITY CLINICS 2021–2027 ($ MILLION)
EXHIBIT 72 US FERTILITY TEST MARKET BY HOSPITALS: INCREMENTAL AND ABSOLUTE GROWTH
EXHIBIT 73 US FERTILITY TEST MARKET BY HOSPITALS 2021–2027 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 US FERTILITY TEST KIT MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 4 US HEALTHCARE DENIAL MANAGEMENT MARKET BY PRODUCT 2021−2027 (%)
TABLE 5 LIST OF SOME OF THE OVULATION TEST KITS AVAILABLE IN THE US
TABLE 6 LIST OF FEW FERTILITY MONITORS AVAILABLE IN US
TABLE 7 US FERTILITY TEST MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 8 US FERTILITY TEST MARKET BY GENDER 2021−2027 (%)
TABLE 9 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021−2027 ($ MILLION)
TABLE 10 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNELS 2021−2027 (%)
TABLE 11 US FERTILITY TEST MARKET BY END-USERS 2021−2027 ($ MILLION)
TABLE 12 US FERTILITY TEST MARKET BY END-USER 2021−2027 (%)
TABLE 13 TOP TEN IVF CLINICS AVAILABLE IN US
TABLE 14 AB ANALITICA: MAJOR PRODUCT OFFERINGS
TABLE 15 ADVACARE PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 16 BIOZHENA: MAJOR PRODUCT OFFERINGS
TABLE 17 DNA DIAGNOSTICS CENTER: MAJOR PRODUCT OFFERINGS
TABLE 18 VIO HEALTH TECH: MAJOR PRODUCT OFFERINGS
TABLE 19 FAIRHAVEN HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 20 HAMILTON THORNE: MAJOR PRODUCT OFFERINGS
TABLE 21 HILIN LIFE PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 22 GIVE LEGACY: MAJOR PRODUCT OFFERINGS
TABLE 23 IXENSOR: MAJOR PRODUCT OFFERINGS
TABLE 24 LADY TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 25 LETSGETCHECKED: MAJOR PRODUCT OFFERINGS
TABLE 26 MEDICAL ELECTRONIC SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 27 MODERN FERTILITY: MAJOR PRODUCT OFFERINGS
TABLE 28 NATALIST: MAJOR PRODUCT OFFERINGS
TABLE 29 OOVA: MAJOR PRODUCT OFFERINGS
TABLE 30 PREMOM: MAJOR PRODUCT OFFERINGS
TABLE 31 QUANOVATE: MAJOR PRODUCT OFFERINGS
TABLE 32 RAIING MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 33 SUGENTECH: MAJOR PRODUCT OFFERINGS
TABLE 34 SAMPLYTICS TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 35 SWIMCOUNT: MAJOR PRODUCT OFFERINGS
TABLE 36 SWISS PRECISION DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 37 TECO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 38 UEBE MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 39 VALLEY ELECTRONICS: MAJOR PRODUCT OFFERINGS
TABLE 40 US FERTILITY TEST KIT MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 41 US HEALTHCARE DENIAL MANAGEMENT MARKET BY PRODUCT 2021−2027 (%)
TABLE 42 US FERTILITY TEST MARKET BY GENDER 2021−2027 ($ MILLION)
TABLE 43 US FERTILITY TEST MARKET BY GENDER 2021−2027 (%)
TABLE 44 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021−2027 ($ MILLION)
TABLE 45 US FERTILITY TEST MARKET BY DISTRIBUTION CHANNEL 2021−2027 (%)
TABLE 46 US FERTILITY TEST MARKET BY END USERS 2021−2027 ($ MILLION)
TABLE 47 US FERTILITY TEST MARKET BY END USER 2021−2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
